Expression of matrix metalloproteinase (gelatinase) in T1 adenocarcinoma of the lung

Pathology International

Volumn 47, Issue 7, 1997, Pages 461-469

  Kodate, Mantaro ^a   Kasai, Takahiko ^a   Hashimoto, Hiroshi ^a   Yasumoto, Kosei ^a   Iwata, Yasushi ^b   Manabe, Hideo ^b  

^a UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

^b KYUSHU KOSEI NENKIN HOSPITAL   (Japan)

Author keywords

Fibrosis; Matrix metalloproteinase; T1 adenocarcinoma of the lung

Indexed keywords

GELATINASE; MATRIX METALLOPROTEINASE;

ARTICLE; CANCER GRADING; CANCER INCIDENCE; CANCER SURVIVAL; FEMALE; GENE EXPRESSION; HISTOLOGY; HUMAN; HUMAN CELL; LUNG ADENOCARCINOMA; LUNG CARCINOMA; LUNG FIBROSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS;

EID: 0030927413     PISSN: 13205463     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1827.1997.tb04525.x     Document Type: Article

References (51)

1. Naruke T, Goya T, Tsuchiya R, Suemasu K. Prognosis and survival in resected lung carcinoma based on new international staging system. J. Thorac. Cardiovasc. Surg. 1988; 96: 440-447.
2. Motohiro A, Hara N, Ichinose Y et al. Evaluation of prognostic factors in early lung cancer. Jpn. J. Cancer Chemotherapy 1990; 17: 31-36 (in Japanese with English abstract).
3. Liotta LA, Rao CN, Barsky SH. Tumor invasion and the extracellular matrix. Lab. Invest. 1983; 49: 636-649.
4. Bolon I, Gouyer V, Devouassoux M et al. Expression of c-est-1, collagenase 1, and urokinase-type plasminogen activator genes in lung carcinomas. Am. J. Pathol. 1995; 147: 1298-1310.
5. Pyke C, Ralfkiær E, Rønne E, Høyer-Hansen G, Kirkeby L, Danø K. Immunohistochemical detection of the receptor for urokinase plasminogen activator in human colon cancer. Histopathology 1994; 24: 131-138.
6. Sloane BF, Honn KV. Cystein proteinases and metastases. Cancer Metastasis Rev. 1984; 3: 249-263.
7. Sukoh N, Abe S, Nakajima I et al. Immunohistochemical distributions of cathepsin B and basement membrane antigens in human lung adenocarcinoma: Association with invasion and metastasis. Virchows Archiv. 1994; 424: 33-38.
8. Campo E, Merino MJ, Liotta LA, Neumann R, Stetler-Stevenson WG. Distribution of the 72-kd type IV collagenase in non-neoplastic and neoplastic thyroid tissue. Hum. Pathol. 1992; 23: 1395-1401.
9. Grigioni WF, Errico A, Fiolentino M et al. Gelatinase A (MMP-2) and its mRNA detected in both neoplastic and stromal cells of tumors with different invasive and metastatic properties. Diagn. Mol. Pathol. 1994; 3: 163-169.
10. Liabakk NB, Talbot I, Smith RA, Wilkinson K, Balkwill F. Matrix metalloprotease 2 (MMP-2) and matrix metalloprotease 9 (MMP-9) type IV collagenases in colorectal cancer. Cancer Res. 1996; 56: 190-196.
11. Sasaguri Y, Komiya T, Sugama K et al. Production of matrix metalloproteinases 2 and 3 (stromelysin) by stromal cells of giant cell tumor of bone. Am. J. Pathol. 1992; 141: 611-621.
12. Shima I, Sasaguri Y, Kusukawa J et al. Production of matrix metalloproteinase-2 and metalloproteinase-3 related to malignant behavior of esophageal carcinoma: A clinicopathological study. Cancer 1992; 70: 2747-2753.
13. Boag AH, Young ID. Immunohistochemical analysis of type IV collagenase expression in prostatic hyperplasia and adenocarcinoma. Mod. Pathol. 1993; 6: 65-68.
14. Gress TM, Müller-Pillasch F, Lerch MM, Fries H, Büchler M, Adler G. Expression and in situ localization of genes coding for extracellular matrix proteins and extracellular matrix degrading proteases in pancreatic cancer. Int. J. Cancer 1995; 62: 407-413.
15. Juarez J, Clayman G, Nakajima M et al. Role and regulation of expression of 92-kDa type-IV collagenase (MMP-9) in two invasive squamous cell carcinoma cell lines of the oral cavity. Int. J. Cancer 1993; 55: 10-18.
16. Shima I, Sasaguri Y, Kusukawa J et al. Production of matrix metalloproteinase 9 (92-kDa gelatinase) by human oesophageal squamous cell carcinoma in response to epidermal growth factor. Br. J. Cancer 1993; 67: 721-727.
17. Shimosato Y, Suzuki A, Hashimoto T et al. Prognostic implications of fibrotic focus (scar) in small peripheral lung cancers. Am. J. Surg. Pathol. 1980; 4: 365-373.
18. Yamashiro K, Yasuda S, Nagase A, Hirata T, Nojima T, Nagashima K. Prognostic significance of an interface pattern of central fibrosis and tumor cells in peripheral adenocarcinoma of the lung. Hum. Pathol. 1995; 26: 67-73.
19. Matsui K, Kitagawa M, Sugiyama S, Yamamoto K. Distribution pattern of the basement membrane components is one of the significant prognostic correlates in peripheral lung adenocarcinomas. Hum. Pathol. 1995; 26: 186-194.
20. Cagle PT, Cohle SD, Greenberg SD. Natural history of pulmonary scar cancers. Cancer 1985; 56: 2031-2035.
21. Madri JA, Carter D. Scar cancer of the lung. Hum. Pathol. 1984; 15: 625-631.
22. Fraig M, Ertorky M, Stetler-Stevenson WG, Koss MN, Fishback N, Travis WD. Immunohistochemical localization of matrix metalloproteinases and its tissue inhibitors in scar carcinoma of the lung (abstract). Lab. Invest. 1996; 74: A155.
23. International Histological Classification of Tumors: Histological Typing of Lung Tumors, 2nd edn. World Health Organization Geneva 1981.
24. International Union Against Cancer (UICC). TNM Classification of Malignant Tumours, 4th edn. Springer-Verlag, Berlin Heidelberg 1987.
25. Sasaguri Y, Yanagi H, Nagase H, Nakano R, Fukuda S, Morimatsu M. Collagenase production by immortalized human aortic endothelial cells infected with simian virus 40. Virchows Arch. B Cell Pathol. 1991; 60: 91-97.
26. Morodomi T, Ogata Y, Sasaguri Y, Morimatsu M, Nagase H. Purification and characterization of matrix metalloproteinase 9 from U937 monocytic leukaemia and HT1080 fibrosarcoma cells. Biochem. J. 1992; 285: 603-611.
27. Ogata Y, Pratta M, Nagase H, Arner EC. Matrix metalloproteinase 9 (92-kDa gelatinase/type IV collagenase) is induced in rabbit articular chondrocytes by cotreatment with interleukin 1ß and a protein kinase C activator. Exp. Cell Res. 1992; 201: 245-249.
28. Ito A, Nose T, Takahashi S, Mori Y. Cyclooxygenase inhibitors augment the production of pro-matrix metalloproteinase 9 (progelatinase B) in rabbit articular chondrocytes. FEBS Lett. 1995; 360: 75-79.
29. Sato T, Ito A, Ogata Y, Nagase H, Mori Y. Tumor necrosis factor α (TNFα) induces pro-matrix metalloproteinase 9 production in human uterine cervical fibroblasts but interleukin 1α antagonizes the inductive effect of TNFα. FEBS Lett. 1996; 392: 175-178.
30. Ito A, Nagase H. Evidence that human rheumatoid synovial matrix metalloproteinase 3 is an endogenous activator of procollagenase. Arch. Biochem. Biophys. 1988; 267: 211-216.
31. Sasaguri Y, Sanford T, Aguirre P, Padmanabhan R. Immunological analysis of 140-kDa adenovirus-encoded DNA polymerase in adenovirus type 2-infected HeLa cells using antibodies raised against the protein expressed in Escherichia coli. Virology 1987; 160: 389-399.
32. Shima I, Sasaguri Y, Arima N et al. Expression of epidermal growth factor (EGF), matrix metalloproteinase-9 (MMP-9) and proliferating cell nuclear antigen (PCNA) in esophageal cancer. Int. J. Oncol. 1995; 6: 833-839.
33. Roberts TE, Hasleton PS, Musgrove C, Swindell R, Lawson RAM. Vascular invasion in non-small cell lung carcinoma. J. Clin. Pathol. 1992; 45: 591-593.
34. Pyke C, Ralfkiær E, Tryggvason K, Danø K. Messenger RNA for two type IV collagenases is located in stromal cells in human colon cancer. Am. J. Pathol. 1993; 142: 359-365.
35. Boag AH, Young ID. Increased expression of the 72-kD type IV collagenase in prostatic adenocarcinoma. Am. J. Pathol. 1994; 144: 585-591.
36. Poulsom R, Hanby AM, Pignatelli M et al. Expression of gelatinase A and TIMP-2 mRNAs in desmoplastic fibroblasts in both mammary carcinomas and basal cell carcinomas of the skin. J. Clin. Pathol. 1993; 46: 429-436.
37. Polette M, Gilbert N, Stas I et al. Gelatinase A expression and localization in human breast cancers: An in situ hybridization study and immunohistochemical detection using confocal microscopy. Virchows Archiv. 1994; 424: 641-645.
38. Nomura H, Sato H, Seiki M, Mai M, Okada Y. Expression of membrane-type matrix metalloproteinase in human gastric carcinomas. Cancer Res. 1995; 55: 3263-3266.
39. Sato H, Takino T, Okada Y et al. A matrix metalloproteinase expressed on the surface of invasive tumor cells. Nature 1994; 370: 61-65.
40. Yu M, Sato H, Seiki M, Thompson EW. Complex regulation of membrane-type matrix metalloproteinase expression and matrix metalloproteinase-2 activation by Concanavalin A in MDA-MB-231 human breast cancer cells. Cancer Res. 1995; 55: 3272-3277.
41. Urbanski SJ, Edwards DR, Maitland A, Leco KJ, Watson A, Kossakowska AE. Expression of metalloproteinases and their inhibitors in primary pulmonary carcinomas. Br. J. Cancer 1992; 66: 1188-1194.
42. Stahle-Backdahl M, Parks WC. 92-kd gelatinase is actively expressed by eosinophils and stored by neutrophils in squamous cell carcinoma. Am. J. Pathol. 1993; 142: 995-1000.
43. Naylor MS, Stamp GW, Davies BD, Balkwill FR. Expression and activity of MMPs and their regulators in ovarian cancer. Int. J. Cancer 1994; 58: 50-56.
44. Noguchi M, Morikawa A, Kawasaki M et al. Small adenocarcinoma of the lung: Histologic characteristics and prognosis. Cancer 1995; 75: 2844-2852.
45. Zeng G and Millis AJT. Expression of 72-kDa gelatinase and TIMP-2 in early and late passage human fibroblasts. Exp. Cell Res. 1994; 213: 148-155.
46. Urbanski SJ, Edwards DR, Hershfield N et al. Expression pattern of metalloproteinases and their inhibitors changes with the progression of human sporadic colorectal neoplasia. Diagn. Mol. Pathol. 1993; 2: 81-89.
47. Zucker S, Lysik RM, Malik M, Bauer BA, Caamano J, Klein-Szanto AJP. Secretion of gelatinases and tissue inhibitors of metalloproteinases by human lung cancer cell lines and revertant cell lines: Not an invariant correlation with metastases. Int. J. Cancer 1992; 52: 366-371.
48. Overall CM, Wrana JL, Sodek J. Transcriptional and post-transcriptional regulation of 72-kDa gelatinase/type IV collagenase by transforming growth factor-β1 in human fibroblasts. J. Biol. Chem. 1991; 266:14 064-14 071.
49. Okada Y, Tsuchiya H, Shimizu H et al. Induction and stimulation of 92-kDa gelatinase/type IV collagenase production in osteosarcoma and fibrosarcoma cell lines by tumor necrosis factor α. Biochem. Biophys. Res. Commun. 1990; 171: 610-617.
50. Ries C, Kolb H, Petrides PE. Regulation of 92-kDa gelatinase release in HL-60 leukemia cells: Tumor necrosis factor-α as an autocrine stimulus for basal- and phorbol ester-induced secretion. Blood 1994; 83: 3638-3646.
51. Wilhelm SM, Collier IE, Marmer BL, Eisen AZ, Grant GA, Goldberg Gl. SV40-transformed human lung fibroblasts secrete a 92-kDa type IV collagenase which is identical to that secreted by normal human macrophages. J. Biol. Chem. 1989; 264: 17 213-17 221.